About this trial
Exercise Rehabilitation (ER) is widely used and effective in the treatment of chronic diseases; however, patients do not adhere to ER programs. Tele-rehabilitation is effective and often used to support and improve patient adherence. Thus, the ADEPINA device could be a promising solution for the individualized management of patients by their therapists. The aim of the study will be: a) To assess functional improvement, measured by the 6-minute walk test (6MWT) after the 12 weeks ER program in people with chronic disease. Additionally, the study will assess the individualized program' adherence and his effect on patients' physical fitness and quality of life. Methods: Fifty patients will follow individualized ER sessions to their patients (with chronic diseases) using the ADEPINA device, 2 to 3 times per week for 12 weeks. At the end of the intervention, the investigator will assess patients' lower limb strength (with sit to stand test), dynamic balance (Timed up and go test), patients' adherence to the ER program by evaluating the usage time of the system by participants, the treatment credibility and participant expectations for improvement will be assessed with the French version of the Credibility and Expectancy Questionnaire. The investigator will also evaluate the patients' quality of life (using the "World Health Organization Quality of Life" (WHOQOL) scale) at the beginning and end of the intervention. Discussion: This interventional pilot study could have positive impacts for participants and explore gaps in the current literature regarding the individualized telerehabilitation program' feasibility.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Be a physiotherapist or kinesiologist working in the public sector, private sector, or in a mixed capacity,
Have been graduated for at least one year,
Conduct ER program with chronic patients and provide written consent.
Be 18 years of age or older,
Disqualifiers
None
Trial design
Single group
Treatments tested in this trial
Telerehabilitation intervention
DeviceInclusion will take place within the framework of routine care for individuals with chronic diseases in rehabilitation services, hospitals, institutions, etc. The study will be offered to patients with chronic illnesses who are being cared for by their therapists. Data collection will be conducted in two sessions. The period between the two sessions will be determined based on the patient's availability, not exceeding a period of 12 weeks: 1. 1st session at 0 week : Conducting activities and initial evaluation at their usual care center. Therapists will perform the various planned tests and evaluations. 2. 2nd session at 12 weeks : This session will take place under the same conditions as the first one and without any potential health risks to the participants. 3. A final evaluation will be carried out at the 18-week follow-up. A telephone call will be made between sessions to check in and assist participants in case of any issues during the study.
Treatment groups
Trial outcomes
Primary outcomes
To assess functional improvement, measured by the 6-minute walk test (6MWT) after the 12 weeks ER program in people with chronic disease.
The investigator will assess the 6-minutes walk distance change after the intervention
Secondary outcomes
To evaluate the impact of the intervention on patient's lower limb strengh
Physical fitness will be assessed using a clinical test (a 30 seconde' sit to stand test) validated and standardized among the chronic disease population.
To evaluate the impact of the intervention on patient's dynamic balance
Physical fitness will be assessed using a clinical test (a time up and go test) validated and standardized among the chronic disease population.
To assess the impact of the intervention onpatient's quality of life
Quality of life will be assessed using the World Health Organization Quality of Life (WHOQOL) questionnaire
The adherence to the rehabilitation exercise program will be assessed by evaluating the system usage time by participants
Specifically, this study will examine program adherence through the rate of patients who completed the intervention sessions and evaluations
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Limoges University
Lead sponsor
Regional Health Agency New Aquitaine
Collaborator
University Hospital, Limoges
Collaborator
This trial is not recruiting at the moment. You can still explore other options: